Skip to main content

Brophy Gerard

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Brophy Gerard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 6, 2023 (view filing)Mar 33 daysBrophy GerardEVP, Biopharma ProductionSSale−3.91K$25.00−$97.8K−3.5%108.7K after
Mar 1, 2023 (view filing)Feb 272 daysBrophy GerardEVP, Biopharma ProductionSSale−3.06K$25.00−$76.5K−2.6%112.6K after
Feb 2, 2023 (view filing)Feb 2Same dayBrophy GerardEVP, Biopharma ProductionSSale−11.3K$25.06−$284.2K−10.0%102.4K after
May 23, 2022 (view filing)May 203 daysBrophy GerardEVP, Biopharma ProductionSSale−19.6K$31.27−$613.0K−16.8%96.9K after
Mar 2, 2022 (view filing)Mar 11 dayBrophy GerardEVP, Biopharma ProductionSSale−2.03K$34.47−$69.9K−1.5%136.2K after
Feb 25, 2022 (view filing)Feb 232 daysBrophy GerardEVP, Biopharma ProductionSSale−3.06K$33.79−$103.4K−2.4%125.2K after
Jan 5, 2022 (view filing)Jan 3-52 daysBrophy GerardEVP, Biopharma ProductionSSale−71.0K$40.42−$2.87M−35.1%131.3K after2 lots
Aug 2, 2021 (view filing)Jul 303 daysBrophy GerardEVP, Biopharma ProductionSSale−81.1K$37.24−$3.02M−35.2%149.4K after